231 related articles for article (PubMed ID: 25970741)
1. Adiponectin, C-reactive protein, fibrinogen and tissue plasminogen activator antigen levels among glucose-intolerant women with and without histories of gestational diabetes.
Kim C; Christophi CA; Goldberg RB; Perreault L; Dabelea D; Marcovina SM; Pi-Sunyer X; Barrett-Connor E
Diabet Med; 2016 Jan; 33(1):32-8. PubMed ID: 25970741
[TBL] [Abstract][Full Text] [Related]
2. Non-traditional biomarkers and incident diabetes in the Diabetes Prevention Program: comparative effects of lifestyle and metformin interventions.
Goldberg RB; Bray GA; Marcovina SM; Mather KJ; Orchard TJ; Perreault L; Temprosa M;
Diabetologia; 2019 Jan; 62(1):58-69. PubMed ID: 30334082
[TBL] [Abstract][Full Text] [Related]
3. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
[TBL] [Abstract][Full Text] [Related]
4. Predicting persistent impaired glucose tolerance in patients with gestational diabetes: The role of high sensitivity CRP and adiponectin.
Durnwald CP; Downes K; Leite R; Elovitz M; Parry S
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29078256
[TBL] [Abstract][Full Text] [Related]
5. Changes in glucose metabolism in people with different glucose metabolism disorders at baseline: follow-up results of a Finnish national diabetes prevention programme.
Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
Diabet Med; 2015 Dec; 32(12):1611-6. PubMed ID: 25864699
[TBL] [Abstract][Full Text] [Related]
6. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort.
Gunderson EP; Kim C; Quesenberry CP; Marcovina S; Walton D; Azevedo RA; Fox G; Elmasian C; Young S; Salvador N; Lum M; Crites Y; Lo JC; Ning X; Dewey KG
Metabolism; 2014 Jul; 63(7):941-50. PubMed ID: 24931281
[TBL] [Abstract][Full Text] [Related]
7. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.
Ratner RE; Christophi CA; Metzger BE; Dabelea D; Bennett PH; Pi-Sunyer X; Fowler S; Kahn SE;
J Clin Endocrinol Metab; 2008 Dec; 93(12):4774-9. PubMed ID: 18826999
[TBL] [Abstract][Full Text] [Related]
8. Rising plasminogen activator inhibitor-1 and hypoadiponectinemia characterize the cardiometabolic biomarker profile of women with recent gestational diabetes.
Mehmood S; Ye C; Connelly PW; Hanley AJ; Zinman B; Retnakaran R
Cardiovasc Diabetol; 2018 Oct; 17(1):133. PubMed ID: 30301460
[TBL] [Abstract][Full Text] [Related]
9. Are third-trimester adipokines associated with higher metabolic risk among women with gestational diabetes?
Honnorat D; Disse E; Millot L; Mathiotte E; Claret M; Charrie A; Drai J; Garnier L; Maurice C; Durand E; Simon C; Dupuis O; Thivolet C
Diabetes Metab; 2015 Nov; 41(5):393-400. PubMed ID: 25890778
[TBL] [Abstract][Full Text] [Related]
10. Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans.
Kim SY; Sy V; Araki T; Babushkin N; Huang D; Tan D; Liao E; Liu G; Wan S; Poretsky L; Seto-Young D
J Diabetes; 2014 Jul; 6(4):360-8. PubMed ID: 24330072
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle intervention in prevention of type 2 diabetes in women with a history of gestational diabetes mellitus: one-year results of the FIN-D2D project.
Rautio N; Jokelainen J; Korpi-Hyövälti E; Oksa H; Saaristo T; Peltonen M; Moilanen L; Vanhala M; Uusitupa M; Tuomilehto J; Keinänen-Kiukaanniemi S
J Womens Health (Larchmt); 2014 Jun; 23(6):506-12. PubMed ID: 24787505
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and abnormal glucose tolerance development after gestational diabetes: A three-year, prospective, randomized, clinical-based, Mediterranean lifestyle interventional study with parallel groups.
Pérez-Ferre N; Del Valle L; Torrejón MJ; Barca I; Calvo MI; Matía P; Rubio MA; Calle-Pascual AL
Clin Nutr; 2015 Aug; 34(4):579-85. PubMed ID: 25262459
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.
Mather KJ; Funahashi T; Matsuzawa Y; Edelstein S; Bray GA; Kahn SE; Crandall J; Marcovina S; Goldstein B; Goldberg R;
Diabetes; 2008 Apr; 57(4):980-6. PubMed ID: 18192541
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
[TBL] [Abstract][Full Text] [Related]
15. Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.
Diabetes Prevention Program Research Group
Diabetes Care; 2005 Oct; 28(10):2472-9. PubMed ID: 16186282
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.
Kim C; Pi-Sunyer X; Barrett-Connor E; Stentz FB; Murphy MB; Kong S; Nan B; Kitabchi AE;
J Clin Endocrinol Metab; 2013 Jul; 98(7):3049-57. PubMed ID: 23709655
[TBL] [Abstract][Full Text] [Related]
17. A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study.
Ferrara A; Hedderson MM; Albright CL; Brown SD; Ehrlich SF; Caan BJ; Sternfeld B; Gordon NP; Schmittdiel JA; Gunderson EP; Mevi AA; Tsai AL; Ching J; Crites Y; Quesenberry CP
BMC Pregnancy Childbirth; 2014 Jan; 14():21. PubMed ID: 24423410
[TBL] [Abstract][Full Text] [Related]
18. Relationship between vitamin D and gestational diabetes in overweight or obese pregnant women may be mediated by adiponectin.
Mousa A; Abell SK; Shorakae S; Harrison CL; Naderpoor N; Hiam D; Moreno-Asso A; Stepto NK; Teede HJ; de Courten B
Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28741856
[TBL] [Abstract][Full Text] [Related]
19. The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up.
Aroda VR; Christophi CA; Edelstein SL; Zhang P; Herman WH; Barrett-Connor E; Delahanty LM; Montez MG; Ackermann RT; Zhuo X; Knowler WC; Ratner RE;
J Clin Endocrinol Metab; 2015 Apr; 100(4):1646-53. PubMed ID: 25706240
[TBL] [Abstract][Full Text] [Related]
20. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.
Choi SH; Kwak SH; Youn BS; Lim S; Park YJ; Lee H; Lee N; Cho YM; Lee HK; Kim YB; Park KS; Jang HC
J Clin Endocrinol Metab; 2008 Aug; 93(8):3142-8. PubMed ID: 18492757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
